Akèy › Sklerodèm › Massachusetts › Boston
Etid klinik pou Sklerodèm nan Boston, MA
7 etid pou Sklerodèm ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Ap rekriteFaz 3
- Massachusetts General Hospital, Boston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Ap rekriteFaz 1
- Boston Medical Center, Boston
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Massachusetts General Hospital, Boston
- Boston University (BU), Boston
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
Ap rekriteVolontè an sante akeyi
- Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Ap rekriteFaz 1
- Brigham And Womens Hospital, Boston
Open Label Treprostinil Raynaud's Study
Ap rekriteFaz 4
- Brigham and Women's Hospital, Boston
- Brigham and Women's Hospital, Boston
Etid Sklerodèm nan lòt vil
- New York City, NY11 etid
- Ann Arbor, MI10 etid
- Chicago, IL10 etid
- Houston, TX9 etid
- Los Angeles, CA7 etid
- Durham, NC7 etid
- New Orleans, LA6 etid
- Philadelphia, PA6 etid
- Baltimore, MD6 etid
- Dallas, TX5 etid
- Pittsburgh, PA5 etid
- Miami, FL4 etid
Lòt etid nan Boston
- Kansè nan tete110 etid
- Kansè Poumon ki pa ti selil89 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat60 etid
- Depresyon51 etid
- Kansè Endomèt50 etid
- Leksemi mieloïd egi45 etid
- Kansè pankreyas44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.